Inhibition of NF-κB activation ameliorates sepsis-induced myocardial dysfunction and vascular derangement, as well as inhibiting the expression of multiple pro-inflammatory genes, reducing tissue neutrophil infiltration, and preventing microvascular endothelial leakage. The gene discussed is NFKB1; the disease is Sepsis.